Based on the M3 INC. stock forecast from 0 analysts, the average analyst target price for M3 INC. is not available over the next 12 months. M3 INC.’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of M3 INC. is Slightly Bullish , which is based on 5 positive signals and 3 negative signals. At the last closing, M3 INC.’s stock price was EUR 8.35. M3 INC.’s stock price has changed by -1.76% over the past week, -1.18% over the past month and -40.78% over the last year.
No recent analyst target price found for M3 INC.
No recent average analyst rating found for M3 INC.
Company Overview M3 INC.
M3, Inc. provides medical-related services primarily to physicians and other healthcare professionals through Internet. The company operates through five reporting segments: Medical Platform, Evidence Solutions, Career Solutions, Site Solutions, and Overseas. It operates m3.com, a members-only web site for providing information to the healthcare professionals; MR-kun, where member doctors can independently and continuously receive information on the m3com platform; QOL-kun that provides life support information other than medical information to members; AskDoctors, where registered doctors answer questions about health and illness from the general public; MDLinx for medical professionals in the United States; and Doctors.net.uk, a website that provides developing services for pharmaceutical companies, as well as provides drug information database in France, Germany, and Spain. The company also provides career services for doctors and pharmacists, recruitment, and posting job advertisements through m3.com CAREER. In addition, it engages in the sales activities and marketing operations for pharmaceuticals and medical devices; development, sale, and support business of electronic medical records and medical equipment for medical institutions; survey service for medical professionals; sale and marketing support businesses for pharmaceutical companies, etc. through the Internet; provision of management support and consulting services to medical institutions, and home-visit nursing services; and provision of human resources services for healthcare professionals, as well as operates clinical trial facilities. The company was formerly known as So-netM3, Inc. and changed its name to M3, Inc. in January 2010. M3, Inc. was incorporated in 2000 and is headquartered in Tokyo, Japan. Read Less
M3, Inc. provides medical-related services primarily to physicians and other healthcare professionals through Internet. The company operates through five reporting segments: Medical Platform, Evidence Solutions, Career Solutions, Site Solutions, and Overseas. It operates m3.com, ...Read More
Frequently Asked Questions About M3 INC. (4YC:F) Stock
Stock Target Advisor's fundamental analysis for M3 INC.'s stock is Slightly Bullish .
4YC:F stock's dividend yield is 2.76%.
Our analysis grades 4YC:F stock's dividend yield at F. This means that 4YC:F stock's dividend yield is above 53% of the stocks in the Health Information Services sector in the F exchange.
Based on this 4YC:F may be a average dividend stock for its sector.
Unfortunately we do not have enough data on 4YC:F's stock to indicate what its average analyst target is.
4YC:F stock's Price/Earning ratio is 25.00.
Our analysis grades 4YC:F stock's Price / Earning ratio at D-. This means that 4YC:F stock's Price/Earning ratio is above 40% of the stocks in the Health Information Services sector in the F exchange.
Based on this 4YC:F may be fairly valued for its sector
The last closing price of 4YC:F's stock was EUR 8.35.
The most recent market capitalization for 4YC:F is EUR 6.25B.
Unfortunately we do not have enough analyst data on 4YC:F's stock to indicate whether its price will go up or not.
We can't find any ETFs which contains M3 INC.'s stock.
As per our most recent records M3 INC. has 12,100 Employees.
M3 INC.'s registered address is Akasaka Intercity, Tokyo, Japan, 107-0052.
You can get more information about it from M3 INC.'s website at https://corporate.m3.com.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Positive free cash flow
The company had positive total free cash flow in the most recent four quarters.
Superior return on assets
The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.
Superior total returns
The stock has outperformed its sector peers on average annual total returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile.
High market capitalization
This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.
Superior return on equity
The company management has delivered better return on equity in the most recent 4 quarters than its peers, placing it in the top quartile.
What not to like
Overpriced compared to book value
The stock is trading high compared to its peers median on a price to book value basis.
High volatility
The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.
Overpriced on free cash flow basis
The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
Frequently Asked Questions About M3 INC. (4YC:F) Stock
Stock Target Advisor's fundamental analysis for M3 INC.'s stock is Slightly Bullish .
4YC:F stock's dividend yield is 2.76%.
Our analysis grades 4YC:F stock's dividend yield at F. This means that 4YC:F stock's dividend yield is above 53% of the stocks in the Health Information Services sector in the F exchange.
Based on this 4YC:F may be a average dividend stock for its sector.
Unfortunately we do not have enough data on 4YC:F's stock to indicate what its average analyst target is.
4YC:F stock's Price/Earning ratio is 25.00.
Our analysis grades 4YC:F stock's Price / Earning ratio at D-. This means that 4YC:F stock's Price/Earning ratio is above 40% of the stocks in the Health Information Services sector in the F exchange.
Based on this 4YC:F may be fairly valued for its sector
The last closing price of 4YC:F's stock was EUR 8.35.
The most recent market capitalization for 4YC:F is EUR 6.25B.
Unfortunately we do not have enough analyst data on 4YC:F's stock to indicate whether its price will go up or not.
We can't find any ETFs which contains M3 INC.'s stock.
As per our most recent records M3 INC. has 12,100 Employees.
M3 INC.'s registered address is Akasaka Intercity, Tokyo, Japan, 107-0052.
You can get more information about it from M3 INC.'s website at https://corporate.m3.com.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for 4YC:F !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
